Annual Revenue
$32.31 M
-$7.83 M-19.52%
September 30, 2023
Summary
- As of February 8, 2025, UPC annual revenue is $32.31 million, with the most recent change of -$7.83 million (-19.52%) on September 30, 2023.
- During the last 3 years, UPC annual revenue has risen by +$1.60 million (+5.23%).
- UPC annual revenue is now -32.66% below its all-time high of $47.98 million, reached on September 30, 2021.
Performance
UPC Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
UPC Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -19.5% | - | - |
| 3 y3 years | +5.2% | - | - |
| 5 y5 years | +13.3% | - | - |
UPC Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -32.7% | at low | ||||
| 5 y | 5-year | -32.7% | +5.2% | ||||
| alltime | all time | -32.7% | +13.3% |
Universe Pharmaceuticals Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2023 | $32.31 M(-19.5%) | - | - |
| Sep 2022 | $40.14 M(-16.3%) | - | - |
| Sep 2021 | $47.98 M(+56.3%) | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2020 | $30.70 M(-7.6%) | - | - |
| Sep 2019 | $33.23 M(+16.5%) | - | - |
| Sep 2018 | $28.51 M | - | - |
FAQ
- What is Universe Pharmaceuticals annual revenue?
- What is the all time high annual revenue for Universe Pharmaceuticals?
- What is Universe Pharmaceuticals annual revenue year-on-year change?
What is Universe Pharmaceuticals annual revenue?
The current annual revenue of UPC is $32.31 M
What is the all time high annual revenue for Universe Pharmaceuticals?
Universe Pharmaceuticals all-time high annual revenue is $47.98 M
What is Universe Pharmaceuticals annual revenue year-on-year change?
Over the past year, UPC annual revenue has changed by -$7.83 M (-19.52%)